These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 26269604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
    Ng SS, Gütschow M, Weiss M, Hauschildt S, Teubert U, Hecker TK, Luzzio FA, Kruger EA, Eger K, Figg WD.
    Cancer Res; 2003 Jun 15; 63(12):3189-94. PubMed ID: 12810647
    [Abstract] [Full Text] [Related]

  • 3. Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.
    Zhang Y, Zhang H, Chen J, Zhao H, Zeng X, Zhang H, Qing C.
    Invest New Drugs; 2012 Feb 15; 30(1):8-16. PubMed ID: 20711631
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS, MacPherson GR, Gütschow M, Eger K, Figg WD.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [Abstract] [Full Text] [Related]

  • 5. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
    da Costa PM, da Costa MP, Carvalho AA, Cavalcanti SM, de Oliveira Cardoso MV, de Oliveira Filho GB, de Araújo Viana D, Fechine-Jamacaru FV, Leite AC, de Moraes MO, Pessoa C, Ferreira PM.
    Chem Biol Interact; 2015 Sep 05; 239():174-83. PubMed ID: 26134001
    [Abstract] [Full Text] [Related]

  • 6. In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs.
    El-Aarag BY, Kasai T, Zahran MA, Zakhary NI, Shigehiro T, Sekhar SC, Agwa HS, Mizutani A, Murakami H, Kakuta H, Seno M.
    Int Immunopharmacol; 2014 Aug 05; 21(2):283-92. PubMed ID: 24859059
    [Abstract] [Full Text] [Related]

  • 7. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Int J Oncol; 2012 May 05; 40(5):1501-14. PubMed ID: 22200632
    [Abstract] [Full Text] [Related]

  • 8. Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab.
    Gardner ER, Kelly M, Springman E, Lee KJ, Li H, Moore W, Figg WD.
    Invest New Drugs; 2012 Feb 05; 30(1):90-7. PubMed ID: 20820910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ, Lin HH, Xu QT, Wang MW.
    Vascul Pharmacol; 2005 Aug 05; 43(2):112-9. PubMed ID: 15982930
    [Abstract] [Full Text] [Related]

  • 19. Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo.
    Zhang HZ, Li CY, Wu JQ, Wang RX, Wei P, Liu MH, He MF.
    Phytomedicine; 2018 Sep 15; 48():10-20. PubMed ID: 30195867
    [Abstract] [Full Text] [Related]

  • 20. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.
    J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.